Brown Dennis M 4
4 · Kintara Therapeutics, Inc. · Filed Apr 29, 2021
Insider Transaction Report
Form 4
Brown Dennis M
DirectorChief Scientific Officer10% Owner
Transactions
- Conversion
Common Stock
2021-04-29+750→ 6,818 total - Conversion
Series B Convertible Preferred Stock
2021-04-29−3,000→ 0 totalFrom: 2016-04-29→ Common Stock (750 underlying) - Other
Common Stock
2021-04-29+6→ 6,068 total
Holdings
- 53,750(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The shares were issued as dividends to April 29, 2021 on the reporting person's shares of Series B Preferred Stock.
- [F2]Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock.
- [F3]Each share of Series B Preferred Stock was convertible into 0.25 shares of common stock equating to a conversion price of $32.00.
- [F4]Held by Valent Technologies LLC, of which the reporting person is the sole member and owner and holds sole voting and dispositive power over its shares.